Precision Therapeutics Company Profile

04:42 EDT 24th September 2017 | BioPortfolio

Precision Therapeutics, Inc. is an exciting, fast-growing, personalized cancer management services company founded in 1995 to help physicians determine the most appropriate cancer treatments for their individual patients.

We've developed a patented technique for successfully growing human tumor-derived cells in culture and testing the cultivated cells for drug sensitivity and/or resistance. The company's ChemoFx® Assay is the first application of this technology. The results provide medical and surgical oncologists with patient-specific tumor information that may provide additional insight when determining the appropriate course of treatment for a patient.

The ability to personalize cancer therapy is becoming more critical due to the rapidly increasing number of therapeutic options. With approximately 400 drugs ("America’s Pharmaceutical Companies" – 2000 Survey) in the near-term pipeline, and over 90 currently in use (American Cancer Society), the number of single drug choices is quickly expanding and the potential combinations are exponential.

Physicians can use Precision Therapeutics’ ChemoFx® Assay to assist them in evaluating optimal therapy options for individual patients. Additionally, the biopharmaceutical industry may be able to use our services to improve the selection of effective drugs and responsive tumors to decrease drug development costs significantly.

As part of our ongoing commitment to provide oncology specialists and biopharmaceutical companies with comprehensive tumor analysis services, Precision Therapeutics continues to focus on developing and validating tumor analysis tests to aid in predicting individual tumor behavior.

Precision Therapeutics’ scientific staff has extensive experience in clinical testing and cancer research, and provides services to physicians and biopharmaceutical companies from our headquarters in Pittsburgh, Pennsylvania.


2516 Jane Street
United States of America


Phone: 866.243.6639
Fax: 866.243.2424

News Articles [2184 Associated News Articles listed on BioPortfolio]

Epygenix Therapeutics Receives US FDA Orphan Drug Designation for EPX-300 for the Treatment of ...

PARAMUS, N.J., Aug. 23, 2017/PRNewswire/ -- Epygenix Therapeutics, Inc., a privately held biopharmaceutical company developing precision medicine for rare and catastrophic forms of genetic Read m...

Precision BioSciences adds Fayaz Khazi, Ph.D., as president of PlantSciences

Precision BioSciences has appointed Fayaz Khazi, Ph.D., to serve as the president of Precision PlantSciences, a business unit developing innovative, high impact products in the food and agriculture s...

FDA Grants Fast Track Designation for Amicus Therapeutics' Migalastat for Treatment of Fabry Disease

CRANBURY, N.J., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the oral precisio...

Biomarker Data Management: A New Foundation for Insights from Translational Research

ArticleDelivering on the promise of precision medicine requires new approaches and informatics platforms to address new challenges.

Precision medicine: a nurses perspective

Adrienne Vazquez talks to ecancer at NOSCM 2017 about precision medicine from a nurses perspective. She goes on to discuss the ways in which the University of Miami operates in relation to precision m...

Shire’s David Thompson Joins Precision BioSciences C-Suite

Precision Biosciences has appointed David Thompson to the new position of chief development officer. Thompson comes to Durham, NC-based Precision from Shire (NASDAQ: SHPG), where he was senior vice pr...

Sarepta Therapeutics Announces Positive Results in Its Study Evaluating Gene Expression, Dystrophin Production, and Dystrophin Localization in Patients with Duchenne Muscular Dystrophy (DMD) Amenable to Skipping Exon 53 Treated with Golodirsen (SRP-4053)

CAMBRIDGE, Mass., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision geneti...

6 findings from HIMSS 2017 Precision Medicine Study

The combination of precision medicine and information technology (IT) has the potential to improve patient outcomes. But many healthcare organizations are slow to pursue integration. A recently releas...

Drugs and Medications [64 Associated Drugs and Medications listed on BioPortfolio]

Loperamide hydrochloride [Precision Dose Inc.]


Childrens acetaminophen [Precision Dose Inc.]


Childrens cetirizine hydrochloride [Precision Dose Inc.]


Aldex [Pernix Therapeutics, LLC]

ALDEX GS™ Tablets

Aldex [Pernix Therapeutics, LLC]


PubMed Articles [1019 Associated PubMed Articles listed on BioPortfolio]

Implementing Clinical Prediction Models: Pushing the Needle Towards Precision Pharmacotherapy.

Clinical prediction models promise a future of precision drug therapy. However, very few models are used in practice. Although models can eliminate unwanted clinical guesswork, several barriers hinder...

Charting a Course for Precision Oncology.

Fields of science have undergone dramatic reorganizations as they have come to terms with the realities of the growing complexities of their problem set, the costs, and the breadth of skills needed to...

Transplantomics: Towards Precision Medicine in Transplantation Research.

Precision medicine is an emerging integrative approach for disease prevention, early detection and treatment that takes into account individual variability in genetic and other molecular measurements,...

Data Sharing, Clinical Trials and Biomarkers in Precision Oncology Challenges, Opportunities and Programs at the Department of Veterans Affairs.

Cancer genomic research reveals that a similar cancer clinical phenotype (e.g. non-small cell lung cancer) can arise from various mutations in tumor DNA. Thus, organ of origin is not a definitive clas...

Functional precision cancer medicine-moving beyond pure genomics.

The essential job of precision medicine is to match the right drugs to the right patients. In cancer, precision medicine has been nearly synonymous with genomics. However, sobering recent studies have...

Clinical Trials [316 Associated Clinical Trials listed on BioPortfolio]

Instrument Precision Study for Validation of Philips Dx

The objective of this study is to evaluate precision of the Philips Dx system.

Dendritic Cell-precision T Cell for Neo-antigen in the Treatment of Advanced Biliary Tract Malignant Tumor

Objectives: The purpose of this study is to evaluate the safety and prognosis of dendritic cell-precision T cell for neo-antigen in the treatment of advanced biliary tract malignant ...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

Deep Brain Stimulation (DBS) for Obsessive Compulsive Disorder (OCD): Improving Targeting Precision

When comparing targeting precision between DBS in parkinsonian patients and OCD patients, an unexpected deviation from the planned targets was discovered in OCD patients (Nuttin et al., 20...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Companies [1493 Associated Companies listed on BioPortfolio]

Precision Therapeutics Inc.

Precision Therapeutics, a leading life-science company based in Pittsburgh, Pennsylvania, is dedicated to personalized cancer care. Precision offers a portfolio of products dev...

Precision Biologics Inc.

Founded in February 2012 and commencing business in late September 2012, Precision Biologics, Inc. is a clinical stage biotechnology corporation focused on developing therapeutic ...

Precision Spine, Inc.

Precision Spine, Inc. is a privately held company with its executive headquarters in Parsippany, NJ. Precision Spine is the parent company of its wholly owned subsidiaries, Spinal...

Precision Eforming LLC

Precision Eforming is a world class manufacturing company of high accuracy Electroformed Products. Originally developed by Buckbee Mears in the 1960's, Precision Eforming's extraordinary processes is ...

Precision for Medicine, Inc.

Precision for Medicine is a specialized service company providing services and infrastructure to support life science companies as they develop new products in the age of precisio...

More Information about "Precision Therapeutics" on BioPortfolio

We have published hundreds of Precision Therapeutics news stories on BioPortfolio along with dozens of Precision Therapeutics Clinical Trials and PubMed Articles about Precision Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Precision Therapeutics Companies in our database. You can also find out about relevant Precision Therapeutics Drugs and Medications on this site too.

Quick Search

Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record